Yoga of Immortals Intervention Reduces Symptoms of Depression, Insomnia and Anxiety.

Autor:	Verma S; University of Cincinnati College of Medicine, Cincinnati, OH, United States., Donovan J; University of Cincinnati College of Medicine, Cincinnati, OH, United States., Tunuguntla HS; Rutgers-Robert Wood Johnson Hospital, New Brunswick, NJ, United States., Tunuguntla R; Internist, Hunterdon Center for Healthy Ageing, Flemington, NJ, United States., Gupta BV; Psychiatrist, Neuropsych Center of Greater Cincinnati, Cincinnati, OH, United States., Nandi A; Johns Hopkins University School of Medicine, Baltimore, MD, United States., Shivanand I; SYC Infinite, San Francisco, CA, United States.
Jazyk:	angličtina
Zdroj:	Frontiers in psychiatry [Front Psychiatry] 2021 Jun 22; Vol. 12, pp. 648029. Date of Electronic Publication: 2021 Jun 22 (Print Publication: 2021).
DOI:	10.3389/fpsyt.2021.648029
Abstrakt:	Background: Depression, anxiety, and disordered sleep are some common symptoms associated with sub-optimal mental health. During the COVID-19 pandemic, mental health issues have grown increasingly more prevalent in the population. Due to social distancing and other limitations during the pandemic, there is a need for home-based, flexible interventions that can improve mental health. The Yoga of Immortals (YOI) mobile application provides a structured intervention that can be used on any mobile device and applied from the user's home. Methods: A total of 1,505 participants were enrolled in the study and used the YOI app for an 8-week period. Participants were asked to fill out three questionnaires: The Patient Health Questionnaire, 8 items (PHQ-8), the Generalized Anxiety Disorder questionnaire (GAD-7) and the Insomnia Severity Index (ISI). These three items were completed by 1,297 participants a total of four times: before starting YOI, two more times during use, and a fourth time after the 8-week usage period. Changes in PHQ8, GAD7 and ISI in participants were compared to a control group, who did not use the YOI app but completed all questionnaires (590 controls finished all questionnaires). Results: Participants reported significant decreases in depression and anxiety-related symptoms. Compared to baseline, PHQ-8 scores decreased 50% on average after the 8-week period. GAD-7 scores also decreased by 40-50% on average, and ISI scores decreased by 50%. These changes were significantly greater ( p < 0.05) than that observed in the control group. Participants who reported a previous diagnosis of depression and generalized anxiety reported significantly larger decreases in PHQ-8 and GAD-7 as compared to participants with no prior diagnosis ( p < 0.05). Conclusions: Regular use of the YOI intervention over an 8-week period led to significant decreases in symptoms of both depression and anxiety, as well as alleviation of insomnia. Competing Interests: IS was employed by the company SYC Infinite. SYC Infinite did not provide any funding for this study and had no role in the study. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. (Copyright © 2021 Verma, Donovan, Tunuguntla, Tunuguntla, Gupta, Nandi and Shivanand.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu